Intracellular markers of senescence, such as p53, p16Ink4a, IL-6, and HMGB1, were considerably decreased in the brains of old-aged 3xTg AD mice treated with 1 mg/kg of GV1001 (Figure 5D). This evidence concerns the gene CDKN2A and Alzheimer disease.